KBC Group NV Sells 10,601 Shares of UnitedHealth Group Incorporated (UNH)
KBC Group NV reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 309,127 shares of the healthcare conglomerate’s stock after selling 10,601 shares during the period. KBC Group NV’s holdings in UnitedHealth Group were worth $57,319,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Waldron LP lifted its position in UnitedHealth Group by 153.1% during the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock valued at $944,000 after acquiring an additional 3,487 shares during the period. Webster Bank N. A. lifted its position in UnitedHealth Group by 27.0% during the 1st quarter. Webster Bank N. A. now owns 913 shares of the healthcare conglomerate’s stock valued at $149,000 after acquiring an additional 194 shares during the period. Adell Harriman & Carpenter Inc. lifted its position in UnitedHealth Group by 36.3% during the 1st quarter. Adell Harriman & Carpenter Inc. now owns 13,096 shares of the healthcare conglomerate’s stock valued at $2,148,000 after acquiring an additional 3,485 shares during the period. Hussman Strategic Advisors Inc. purchased a new position in UnitedHealth Group during the 1st quarter valued at about $4,100,000. Finally, ING Groep NV lifted its position in UnitedHealth Group by 42.3% during the 1st quarter. ING Groep NV now owns 270,278 shares of the healthcare conglomerate’s stock valued at $44,328,000 after acquiring an additional 80,289 shares during the period. 86.11% of the stock is owned by institutional investors.
UNH has been the subject of a number of recent research reports. Cantor Fitzgerald reissued an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a research report on Friday, July 21st. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Finally, BidaskClub cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $215.27.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The disclosure for this sale can be found here. Insiders have sold a total of 76,174 shares of company stock valued at $14,981,909 over the last three months. 0.89% of the stock is currently owned by insiders.
Shares of UnitedHealth Group Incorporated (UNH) opened at 203.25 on Friday. The company’s 50-day moving average is $197.17 and its 200 day moving average is $185.63. UnitedHealth Group Incorporated has a 12 month low of $133.03 and a 12 month high of $207.80. The company has a market capitalization of $201.01 billion, a price-to-earnings ratio of 23.08 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the firm posted $2.17 EPS. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post $9.91 earnings per share for the current year.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.